N syndrome

Common Name(s)

N syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "N syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "N syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "N syndrome" returned 142 free, full-text research articles on human participants. First 3 results:

N-Methyl-D-Aspartate Receptors, Ketamine, and Rett Syndrome: Something Special on the Road to Treatments?
 

Author(s): David M Katz, Frank S Menniti, Robert J Mather

Journal: Biol. Psychiatry. 2016 May;79(9):710-2.

 

Last Updated: 15 Apr 2016

Go To URL
Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
 

Author(s): Anne E Barden, Emilie Mas, Kevin D Croft, Michael Phillips, Trevor A Mori

Journal: Am. J. Clin. Nutr.. 2015 Dec;102(6):1357-64.

 

The metabolic syndrome (MetS) is associated with a chronic low-grade inflammatory state and may be affected by the ability to resolve inflammation, which is an active process that involves specialized proresolving lipid mediators (SPMs) derived from n-3 (ω-3) fatty acids.

Last Updated: 2 Dec 2015

Go To URL
NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
 

Author(s): Jillian P Casey, Svein I Støve, Catherine McGorrian, Joseph Galvin, Marina Blenski, Aimee Dunne, Sean Ennis, Francesca Brett, Mary D King, Thomas Arnesen, Sally Ann Lynch

Journal:

 

We report two brothers from a non-consanguineous Irish family presenting with a novel syndrome characterised by intellectual disability, facial dysmorphism, scoliosis and long QT. Their mother has a milder phenotype including long QT. X-linked inheritance was suspected. Whole exome ...

Last Updated: 2 Nov 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "N syndrome" returned 3 free, full-text review articles on human participants. First 3 results:

Use of n-3 PUFAs can decrease the mortality in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.
 

Author(s): Xiao Wan, Xuejin Gao, Jingcheng Bi, Feng Tian, Xinying Wang

Journal:

 

There have been several meta-analyses evaluating the effect of n-3 polyunsaturated fatty acids (PUFAs) in critically ill patients, but of these, none focused on patients with systemic inflammatory response syndrome (SIRS). The objective of this meta-analysis was to evaluate the effect ...

Last Updated: 20 May 2015

Go To URL
[Reversal of acute liver failure with N-acetylcysteine and prednisone in a patient with DRESS syndrome: a case report and literature review].
 

Author(s): E Pérez-Reyes, A Casanova-Lara, E Pérez-Torres, J Córdova

Journal: Rev Gastroenterol Mex. ;79(3):208-10.

 

Last Updated: 3 Oct 2014

Go To URL
n-3 fatty acids and the metabolic syndrome.
 

Author(s): Yvon A Carpentier, Laurence Portois, Willy J Malaisse

Journal: Am. J. Clin. Nutr.. 2006 Jun;83(6 Suppl):1499S-1504S.

 

The metabolic syndrome is defined as the coexistence of 3 or more components, some of which indicate alterations in glucose and lipid metabolism. The prevalence of the metabolic syndrome is rapidly increasing in relation to obesity, and it is considered to be an important predictor ...

Last Updated: 17 Jul 2006

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
 

Status: Recruiting

Condition Summary: Irritable Bowel Syndrome

 

Last Updated: 17 Jul 2015

Go to URL
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
 

Status: Recruiting

Condition Summary: Irritable Bowel Syndrome

 

Last Updated: 23 Jul 2015

Go to URL
NAC in CC Resistant PCOS After LOD
 

Status: Recruiting

Condition Summary: Clomiphene Citrate Resistant Polycystic Ovary Syndrome

 

Last Updated: 17 May 2016

Go to URL